Conagra to Report Q3 FY2026 Earnings April 1
CHICAGO, March 2, 2026 Conagra Brands, Inc. announced it will release its fiscal 2026 third quarter earnings results on...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
CHICAGO, March 2, 2026 Conagra Brands, Inc. announced it will release its fiscal 2026 third quarter earnings results on...
Vancouver, British Columbia — December 2, 2025 — BYT Holdings Ltd. announced its plan to initiate a Normal Course...
BOSTON, October 16, 2025 Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, has announced the successful pricing...
